047 Changes in proteome of membrane fractions from bovine oocyte to zygote J Romero-Aguirregomezcorta, J Peña, P Graván, JG Hamzé, JA Marchal, ... Animal-science proceedings 14 (3), 459-460, 2023 | | 2023 |
1-(Benzenesulfonyl)-1, 5-dihydro-4, 1-benzoxazepine as a new scaffold for the design of antitumor compounds O Cruz-López, A Ramírez, SA Navarro, MA García, JA Marchal, ... Future Medicinal Chemistry 9 (11), 1129-1140, 2017 | 3 | 2017 |
5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation JA Marchal, H Boulaiz, F Rodriguez-Serrano, M Peran, E Carrillo, C Velez, ... Medicinal Chemistry 3 (3), 233-239, 2007 | 13 | 2007 |
5-Fluorouracil derivatives: a patent review P Álvarez, JA Marchal, H Boulaiz, E Carrillo, C Vélez, ... Expert opinion on therapeutic patents 22 (2), 107-123, 2012 | 126 | 2012 |
5-Fluorouracil derivatives: a patent review (2012–2014) E Carrillo, SA Navarro, A Ramírez, MÁ García, C Griñán-Lisón, M Perán, ... Expert opinion on therapeutic patents 25 (10), 1131-1144, 2015 | 53 | 2015 |
5200 A new combined therapy strategy to breast cancer treatment: assay of E gene transfection associated to citotoxic drugs in multicellular tumour spheroid AR Rama, C Melquizo, J Prados, R Ortiz, F Rodriguez-Serrano, H Boulaiz, ... EJC Supplements 2 (7), 319-320, 2009 | | 2009 |
6′-Chloro-7-or 9-(2, 3-dihydro-5H-4, 1-benzoxathiepin-3-yl)-7H-or 9H-purines and their corresponding sulfones as a new family of cytotoxic drugs MC Núñez, F Rodríguez-Serrano, JA Marchal, O Caba, A Aránega, ... Tetrahedron 63 (1), 183-190, 2007 | 29 | 2007 |
95 Transfection of the gene e and later application of cytotoxic drugs in the treatment of breast multicellular tumour solid cancer ARR Ballesteros, J Prados, C Melquizo, R Ortiz, F Rodriguez-Serrano, ... EJC Supplements 3 (8), 86, 2010 | | 2010 |
A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer M Perán, E López-Ruiz, MÁ García, S Nadaraia-Hoke, R Brandt, ... Scientific Reports 7 (1), 13998, 2017 | 16 | 2017 |
A morphometric study of the human fetal heart with perimembranous ventricular septal defects L Alvarez, A Aranega, R Saucedo, JA Marchal, AR González, ... Cardiology in the Young 5 (1), 63-69, 1995 | | 1995 |
A novel biomimetic knee joint bioreactor for the in vitro regeneration of osteochondral lesions N Campillo, A Torres, C Romo, S Micó, C Chocarro-Wrona, J López, ... TISSUE ENGINEERING PART A 28, 358-358, 2022 | 1 | 2022 |
A scalable method for the production of exosomes derived from CAR-T cells P Heredia, K Pavlovic, B Perucha, M Cortijo, V Ronco, F Martin, ... HUMAN GENE THERAPY 33 (23-24), A134-A134, 2022 | | 2022 |
A soft 3D polyacrylate hydrogel recapitulates the cartilage niche and allows growth-factor free tissue engineering of human articular cartilage G Jiménez, S Venkateswaran, E López-Ruiz, M Perán, S Pernagallo, ... Acta Biomaterialia 90, 146-156, 2019 | 29 | 2019 |
A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells JA Marchal, MC Núñez, I Suárez, M Díaz-Gavilán, JA Gómez-Vidal, ... Breast cancer research and treatment 105, 237-246, 2007 | 30 | 2007 |
A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer MV Cano-Cortes, SA Navarro-Marchal, MP Ruiz-Blas, JJ Diaz-Mochon, ... Nanomedicine: Nanotechnology, Biology and Medicine 24, 102120, 2020 | 27 | 2020 |
A worldwide overview of regulatory frameworks for tissue-based products CV Oberweis, JA Marchal, E López-Ruiz, P Gálvez-Martín Tissue Engineering Part B: Reviews 26 (2), 181-196, 2020 | 41 | 2020 |
Abstract P6-05-01: Interactions between adipocytes and breast cancer cells stimulate cytokine production and drive Src/SOX2/miR-302b mediated malignant progression M Picon-Ruiz, C Pan, K Drewes-Elger, K Jang, A Besser, D Zaho, ... Cancer Research 78 (4_Supplement), P6-05-01-P6-05-01, 2018 | | 2018 |
Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells JA Marchal, J Prados, C Melguizo, JE Fernández, C Velez, L Alvarez, ... Journal of Laboratory and Clinical Medicine 130 (1), 42-50, 1997 | 26 | 1997 |
Activating transcription factor 4 modulates TGFβ-induced aggressiveness in triple-negative breast cancer via SMAD2/3/4 and mTORC2 signaling A González-González, E Muñoz-Muela, JA Marchal, FE Cara, MP Molina, ... Clinical Cancer Research 24 (22), 5697-5709, 2018 | 54 | 2018 |
Actividad selectiva de nuevos fármacos con potencial terapeútico frente a cáncer de mama JA Marchal, I Suárez, H Boulaiz, E Carrillo, A Martínez-Amat, FR Serrano, ... Actualidad médica 92 (773), 31-38, 2006 | | 2006 |